Customization: | Available |
---|---|
Assay: | 99%+ |
Product Name: | Vinorelbine Tartrate |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Vinorelbine tartrate |
CAS | 125317-39-7 |
Synonyms | 3′,4′-Didehydro-4′-deoxy-C′-norvincaleukoblastine [R-(R*,R*)-2-3-dihydroxybutanedioate (1:2)salt], 5′-Noranhydrovinoblastine tartrate, |
Appearance | White |
Molecular Formula | C53H66N4O20 |
Molecular Weight | 1079.11 |
Assay | >99% |
Vinorelbine tartrate is the tartrate form of vinorelbine, a semi-synthetic vinblastine compound, which is a M-phase specific drug, and its mechanism of action is similar to that of vincristine. Mainly by selectively blocking tubulin polymerization in mitotic cells to form microtubules, which can induce tubulin depolymerization, hinder the spindle microtubules, stop cell division in the middle stage, and affect the tubulin synthesis of neuronal axons. very little.
Function:
Vinblastine is a medication used to treat a number of types of cancer including: Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, and testicular cancer among others.It is used intravenously and works by inhibiting mitosis.